Compugen, Inc.
Compugen, Inc., a leading biotechnology company headquartered in California, has been at the forefront of immuno-oncology since its establishment in 1998. With a strong presence in North America and Israel, Compugen focuses on the discovery and development of novel therapeutic agents that harness the immune system to combat cancer. The company is renowned for its innovative approach to drug development, particularly its unique computational biology platform that identifies new immune checkpoints and therapeutic targets. Compugen's core products include monoclonal antibodies and immune-modulating therapies, which have shown promise in clinical trials. Recognised for its significant contributions to the field, Compugen has achieved notable milestones, including strategic partnerships with major pharmaceutical companies, solidifying its position as a key player in the biotechnology industry.
DitchCarbon Score
How does Compugen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Compugen, Inc.'s score of 27 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Compugen, Inc.'s reported carbon emissions
In 2022, Compugen, Inc., headquartered in California, reported significant carbon emissions, with a total of approximately 13,567,000 kg CO2e attributed to Scope 3 emissions. Notably, the company did not report any emissions for Scope 1 or Scope 2, indicating a focus on upstream activities. Currently, Compugen has not established any specific reduction targets or initiatives, nor does it participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). The absence of reduction commitments suggests that the company may be in the early stages of developing a comprehensive climate strategy. As a part of the broader industry context, Compugen's emissions data reflects the growing emphasis on transparency and accountability in corporate climate commitments, particularly in the technology sector. The company’s current focus on Scope 3 emissions highlights the importance of addressing supply chain impacts in overall carbon management.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | - |
| Scope 2 | - |
| Scope 3 | 13,567,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Compugen, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
